Kiora PharmaceuticalsKPRX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 22 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, up 4 from Q1 2026. 10 opened new positions and 6 sold out. The largest holders were Perceptive Advisors LLC ($1.2M), ADAR1 Capital Management, LLC ($442K) and Citadel Advisors ($305K). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.0M |
| Exits | 6 | $71K |
All 13F filers, Q1 2026 → Q2 2026: 824,612 shares bought and 58,253 shares sold, net +766,359 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Perceptive Advisors LLC | 0.02% | New | 438,471 | $1.2M |
| ADAR1 Capital Management, LLC | 0.02% | No change | 167,941 | $442K |
| Citadel Advisors | 0.00% | Add +134.2% | 116,011 | $305K |
| Two Sigma Investments, LP | 0.00% | New | 88,792 | $234K |
| Millennium Management | 0.00% | New | 74,202 | $195K |
| HRT Financial LP | 0.00% | New | 58,612 | $154K |
| Renaissance Technologies | 0.00% | New | 29,824 | $78K |
| Geode Capital Management, LLC | 0.00% | Reduce -44.2% | 26,717 | $70K |
| Vanguard Capital Management LLC | 0.00% | No change | 19,861 | $52K |
| Scientech Research LLC | 0.04% | New | 18,746 | $49K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 13,030 | $34K |
| LPL Financial LLC | 0.00% | New | 12,500 | $33K |
| Dimensional Fund Advisors LP | 0.00% | New | 12,138 | $32K |
| Northern Trust Corp. | 0.00% | New | 11,767 | $31K |
| Jane Street Group, LLC | 0.00% | New | 10,615 | $28K |
| UBS Group AG | 0.00% | Add +50.7% | 1,961 | $5K |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +30116.7% | 1,813 | $5K |
| Morgan Stanley | 0.00% | No change | 1,408 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -15.9% | 837 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 256 | $673 |
| BlackRock, Inc. | 0.00% | No change | 58 | $153 |
| Activest Wealth Management | 0.00% | No change | 2 | $5 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.